Statistics; treatment in the UK

Brain surgery: predicting patient outcomes

Artificial Intelligence is increasingly being used to make real inroads in the medical field.  Now neurologists from the Medical University of South Carolina (MUSC) have used artificial intelligence to develop a technique which may eventually help both patients and doctors weigh up the pros and cons of using brain surgery to treat debilitating seizures caused by epilepsy. Although the number read more

Using brain tissue to test the impact of treatments on epilepsy and other neurological conditions

Professor Jurgen Knoblich, a molecular biologist at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences in Vienna is confident that the way to cost effectively test drugs for incurable neurological conditions is to use human brain tissue. To date most new drugs are initially tested on animal models and although the animals are specifically bred to show read more

Protein found in microscopic worms may offer new treatment for drug-resistant epilepsy

Drug-resistant epilepsy is thought to affect about 30% of people with epilepsy, which is more than 200,000 people nationwide.  Now new research has suggested that a protein found in a type of worm could help to reduce the number of epileptic seizures experienced by people whose epilepsy remains uncontrolled.  At the moment the findings have only been witnessed in animal read more

New research shines a light on the ketogenic diet

The ketogenic diet (which is high in protein and low in carbohydrate) has been used for a very long time to treat seizures in people with refractory epilepsy. However no-one has been entirely clear as to why it may be able to help reduce the number and severity of seizures. Now new research suggests that the diet may influence the read more

Could a fungus in the Red Sea lead to new epilepsy treatments

Antiepileptic medication controls seizures for the majority of people with epilepsy however between 30-40% of people will not respond to this medication and will not achieve seizure freedom. Researchers are therefore always looking for new compounds that could potentially treat epilepsy and in order to find new leads they have now started to look at the sea as a unique read more

Call for global action and renewed momentum on epilepsy

Despite its wide-reaching effects, epilepsy is often overlooked as a public health concern which is why three years ago, in 2015, the World Health Organisation (WHO) passed a resolution encouraging countries to prioritise epilepsy and at the same time established a three-year reporting period to track progress. The three year term is set to expire this year, in 2018, which read more

Status epilepticus mortality rates ‘falling in England and Wales”

Posted 18 May 2016 in Statistics; treatment in the UK

New advances in treating status epilepticus are helping to reduce mortality rates associated with the condition in England and Wales. A recent study, led by Queen Mary University of London and University College London, reviewed data from the Office of National Statistics and offered evidence that early treatment of this dangerous condition could improve outcomes. Status epilepticus is characterised by read more

New study highlights need for epilepsy-focused neuropsychiatry services

A new study has demonstrated some of the key priorities that ought to be considered when designing neuropsychiatry services for people with epilepsy. Led by the Birmingham and Solihull Mental Health NHS Foundation Trust and Aston University, this research examined data from 60 patients with epilepsy referred to and assessed within a neuropsychiatry setting, to gauge their needs. Services like read more

VNS therapy ‘can help reduce costs associated with epilepsy care’

Posted 24 Nov 2015 in Statistics; treatment in the UK

A new study from England has indicated that vagus nerve stimulation (VNS) therapy could play a role in helping to reduce the cost of epilepsy care. Conducted by HCD Economics, the Neurosurgeon Royal Hallamshire Hospital,  University College Cork and the University of Chester, the research aimed to compare hospital service use before and after VNS therapy implantation in a sample read more

Page 1 of 41234

News categories